Difference between revisions of "Team:CSU CHINA/Parts"

 
(3 intermediate revisions by the same user not shown)
Line 1: Line 1:
 
{{CSU_CHINA}}
 
{{CSU_CHINA}}
 
<html>
 
<html>
−
 
+
<center>
−
 
+
−
<div class="column full_size">
+
 
<h1>Parts Overview</h1>
 
<h1>Parts Overview</h1>
 +
</center>
 +
<hr>
 +
<div class="block main-text main-text" >
 +
 
<p>
 
<p>
 
We relied heavily on three basic parts from the Registry (CMV,GAL4 and VP16), and so we changed several sites to optimize them. We designed a new composite part BBa_K2580666 to express GAL4-VP16, an potent transcriptional activator[1] , to drive other parts’ expression.
 
We relied heavily on three basic parts from the Registry (CMV,GAL4 and VP16), and so we changed several sites to optimize them. We designed a new composite part BBa_K2580666 to express GAL4-VP16, an potent transcriptional activator[1] , to drive other parts’ expression.
 
</p>
 
</p>
−
<br/><br/><br/><br/><br/>
+
<br/><br/>
−
<p>Each team will make new parts during iGEM and will submit them to the Registry of Standard Biological Parts. The iGEM software provides an easy way to present the parts your team has created. The <code>&lt;groupparts&gt;</code> tag (see below) will generate a table with all of the parts that your team adds to your team sandbox.</p>
+
<h class="highlight-title dark-blue"></br></br>Reference</h>
−
<p>Remember that the goal of proper part documentation is to describe and define a part, so that it can be used without needing to refer to the primary literature. Registry users in future years should be able to read your documentation and be able to use the part successfully. Also, you should provide proper references to acknowledge previous authors and to provide for users who wish to know more.</p>
+
<hr>
 +
<p>
 +
[1] Sadowski I, Ma J, Triezenberg S, et al. GAL4-VP16 is an unusually potent transcriptional activator[J]. Nature, 1988, 335(6190): 563.
 +
</p>
 
</div>
 
</div>
  

Latest revision as of 02:28, 18 October 2018


Parts Overview

We relied heavily on three basic parts from the Registry (CMV,GAL4 and VP16), and so we changed several sites to optimize them. We designed a new composite part BBa_K2580666 to express GAL4-VP16, an potent transcriptional activator[1] , to drive other parts’ expression.





Reference

[1] Sadowski I, Ma J, Triezenberg S, et al. GAL4-VP16 is an unusually potent transcriptional activator[J]. Nature, 1988, 335(6190): 563.